Karen Noblett, Chief Medical Officer at Axonics, Inc. (AXNX), sold 15,051 shares at $63.28 ($952K) on 2023-12-28, disclosed to the SEC on 2023-12-28.
Scheduled sale ($952k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.00 | 949 | $60K | 6.3% |
| 2 | $63.28 | 7,051 | $446K | 46.9% |
| 3 | $63.28 | 7,051 | $446K | 46.9% |
| Total | $63.26 avg | 15,051 | $952K | 100% |
| Filing → |
| AXNX | SELL | 2023-02-02 | $510K | — | Filing → |
| AXNX | SELL | 2022-09-20 | $5.1M | — | Filing → |
| AXNX | SELL | 2022-09-09 | $1.5M | — | Filing → |